Company intelligence / Profile preview

OneTwo Analytics

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Current results include commercial launch of a self-care app (OneTwo Diabetes) using AI and ML for glucose data analysis, and early clinical research demonstrating survival and function of genetically modified insulin-producing islet cells in type 1 diabetes patients without immunosuppression

Therapeutic areas: Endocrinology
Modalities: DeviceAI-driven digital solutionCell therapy
Industry: Biotech

Partnerships

Glucotrack (for clinical data analysis and product evaluation of Continuous Blood Glucose Monitor)

Beyond the preview

Go deeper on OneTwo Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OneTwo Analytics.

Explore the full profile